Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus
- PMID: 25379390
- PMCID: PMC4216327
- DOI: 10.1016/j.mmcr.2014.08.003
Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus
Abstract
Mortality due to AIDS-related Cryptococcal meningitis (CM) is often >50% in low-middle income countries. Dissemination of CM can result in intracranial mass lesions known as cryptococcoma. Patients who develop cryptococcomas often have worse outcomes when compared to patients with cryptococcosis without cryptococcoma. We describe a cryptococcoma in the central nervous system (CNS) in a Ugandan patient with AIDS, and review the diagnosis and management with special focus on difficulties encountered in low or middle-income countries.
Keywords: Central nervous system; Cryptococcoma; Cryptococcus meningitis; Human Immunodeficiency Virus; Immunosuppressed Host.
Figures
References
-
- Jackson A, Hosseinipour MC. Management of cryptococcal meningitis in sub-Saharan Africa. Curr HIV/AIDS Rep. 2010;7(3):134–142. - PubMed
-
- Stevens DA, Denning DW, Shatsky S, Armstrong RW, Adler JD, Lewis BH. Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications. Mycopathologia. 1999;146(1):1–8. - PubMed
-
- Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499–508. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
